alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EX-10.1



 Exhibit 10.1 

SIXTH AMENDMENT TO 

EMPLOYMENT AGREEMENT 

This SIXTH AMENDMENT TO EMPLOYMENT AGREEMENT (“Amendment”) is entered into as of this 25th day of May, 2018, by and between CATALYST PHARMACEUTICALS, INC., a Delaware corporation (“Company”) and PATRICK J. MCENANY (“Employee”). 

Preliminary Statements 
  

	 	A.	The parties have previously entered into that certain Employment Agreement, dated as of November 8, 2006 (the “Original Agreement”), as previously amended by that certain First Amendment to
Employment Agreement, dated as of December 19, 2008 (the “First Amendment”), that certain Second Amendment to Employment Agreement, dated as of November 8, 2009 (the “Second Amendment”), that certain Third
Amendment to Employment Agreement, dated as of September 14, 2011 (the “Third Amendment”), that certain Fourth Amendment to Employment Agreement, dated as of August 28, 2013 (the “Fourth Amendment”), and
that certain Fifth Amendment to Employment Agreement, dated as of June 23, 2016 (the “Fifth Amendment”, and together with the Original Agreement, the First Amendment, the Second Amendment, the Third Amendment, and the Fourth
Amendment, the “Employment Agreement”). Unless otherwise defined, capitalized terms used herein shall have the meanings given to them in the Employment Agreement. 


 

	 	B.	The parties wish to further amend the Employment Agreement to reflect the terms set forth below. 


Agreement 
 NOW, THEREFORE,
in consideration of the premises, the mutual covenants set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows: 

 

	 	1.	Extension of Agreement. The outside date of the Term of the Employment Agreement is extended for a two year period from the “twelfth anniversary of the Effective Date” (November 8, 2018) until the
“fourteenth anniversary of the Effective Date” (November 8, 2020). All references in the Employment Agreement to the “third anniversary of the Effective Date”, the “fifth anniversary of the Effective Date”, the
“seventh anniversary of the Effective Date”, the “tenth anniversary of the Effective Date” or the “twelfth anniversary of the Effective Date” shall be deemed by this Amendment to now refer to the “fourteenth
anniversary of the Effective Date.” 

  

	 	2.	Employment Agreement Remains in Effect. Except as otherwise specifically amended herein, the terms and provisions of the Employment Agreement remain in full force and effect. 


  
 1 









	 	3.	Counterparts. This Amendment may be executed in counterparts. 

 IN WITNESS
WHEREOF, the parties have executed this Amendment, effective as of the date set forth above. 
  

			
	CATALYST PHARMACEUTICALS, INC.


 
			
		
	By:	 	 /s/ Alicia Grande

		 	Alicia Grande
		 	Vice President, Treasurer and CFO


 
			
	
	EMPLOYEE:
	
	 /s/ Patrick J. McEnany

	Patrick J. McEnany



  
 2
Debby GENTHNER, petitioner, v. M. Bruce SMITH, Judge, Court of Appeals of California, Fifth Appellate District, et al.

No. 16-9602.

Supreme Court of the United States

Oct. 2, 2017.

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.
Manuel SILE-PEREZ, petitioner, v. UNITED STATES.

No. 17-7969.

Supreme Court of the United States

April 2, 2018.

Petition for writ of certiorari to the United States Court of Appeals for the Sixth Circuit denied.
Edgar Julian DIETRICH, petitioner, v. CITY OF GROSSE POINTE PARK, MICHIGAN, et al.

No. 17-7098.

Supreme Court of the United States

April 16, 2018.

Petition for rehearing denied.
# C_2010148EN.01003102.xml

| 5.6.2010 | EN | Official Journal of the European Union | C 148/31 |
| --- | --- | --- | --- |

5.6.2010

EN

Official Journal of the European Union

C 148/31

---

Action brought on 6 April 2010 — Ayadi v Commission

(Case T-527/09)

2010/C 148/56

Language of the case: English

Parties

Parties

Applicant: Chafiq Ayadi (represented by: H. Miller Solicitor, B. Emmerson and S. Cox, Barristers)

Applicant:

Defendant: European Commission

Defendant:

Form of order sought

Form of order sought

| — | annul Commission Regulation No 954/2009, in so far as it applies to the applicant; |
| --- | --- |

—

annul Commission Regulation No 954/2009, in so far as it applies to the applicant;

| — | order the Commission to pay the costs. |
| --- | --- |

—

order the Commission to pay the costs.

Pleas in law and main arguments

Pleas in law and main arguments

In the present case, the applicant seeks the partial annulment of Commission Regulation (EC) No 954/2009 of 13 October 2009 amending for the 114th time Council Regulation (EC) No 881/2002 imposing certain specific restrictive measures directed against certain persons and entities associated with Usama bin Laden, the Al-Qaida network and the Taliban in so far as the applicant is included on the list of natural and legal persons, entities and bodies whose funds and economic resources are frozen in accordance with this provision.

The applicant puts forward four pleas in law in support of its claims.

First, the applicant submits that the Commission misused its power by including the applicant in Annex I to Regulation No 881/2002 without having carefully and impartially examined all the relevant elements of the applicant’s case.

Second, the applicant claims that the contested regulation was adopted in breach of the applicant’s right to effective judicial review since the regulation lacked of evidential basis and, in consequence, the Court is unable even to begin to exercise its duty of considering that evidence.

Third, the applicant argues that the contested regulation was adopted in breach of the applicant’s right of defence. He submits that the Commission failed to provide a statement of evidence but only provided the allegations in the Sanctions Committee statement. Without the evidence, the applicant was unable to address the Commission on defects in that evidence or misunderstandings.

Fourth, he claims that the contested regulation, freezing the applicant’s assets both retrospectively and, for an indefinite period, prospectively, constitutes an unjustified restriction on his fundamental right of property.

---
# L_2005339EN.01005301.xml

| 22.12.2005 | EN | Official Journal of the European Union | L 339/53 |
| --- | --- | --- | --- |

22.12.2005

EN

Official Journal of the European Union

L 339/53

---

DECISION OF THE EEA JOINT COMMITTEE

No 128/2005

of 30 September 2005

amending Annex XXI (Statistics) to the EEA Agreement

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area, as amended by the Protocol adjusting the Agreement on the European Economic Area, hereinafter referred to as ‘the Agreement’, and in particular Article 98 thereof,

Whereas:

| (1) | Annex XXI to the Agreement was amended by Decision of the EEA Joint Committee No 86/2005 of 10 June 2005 (1). |
| --- | --- |

(1)

Annex XXI to the Agreement was amended by Decision of the EEA Joint Committee No 86/2005 of 10 June 2005 (1).

| (2) | Commission Regulation (EC) No 306/2005 of 24 February 2005 amending Annex I to Regulation (EC) No 138/2004 of the European Parliament and of the Council on the economic accounts for agriculture in the Community (2) is to be incorporated into the Agreement, |
| --- | --- |

(2)

Commission Regulation (EC) No 306/2005 of 24 February 2005 amending Annex I to Regulation (EC) No 138/2004 of the European Parliament and of the Council on the economic accounts for agriculture in the Community (2) is to be incorporated into the Agreement,

HAS DECIDED AS FOLLOWS:

Article 1

The following shall be added in point 24c (Regulation (EC) No 138/2004 of the European Parliament and of the Council) of Annex XXI to the Agreement:

‘, as amended by:

| — | 32005 R 0306: Commission Regulation (EC) No 306/2005 of 24 February 2005 (OJ L 52, 25.2.2005, p. 9).’ |
| --- | --- |

—

32005 R 0306: Commission Regulation (EC) No 306/2005 of 24 February 2005 (OJ L 52, 25.2.2005, p. 9).’

Article 2

The text of Regulation (EC) No 306/2005 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3

This Decision shall enter into force on 1 October 2005, provided that all the notifications under Article 103(1) of the Agreement have been made to the EEA Joint Committee (*1).

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 30 September 2005.

For the EEA Joint Committee

The President

HSH Prinz Nikolaus von LIECHTENSTEIN

---

(1)  
  OJ L 268, 13.10.2005, p. 21.

1

(2)  
  OJ L 52, 25.2.2005, p. 9.

2

(*1)  No constitutional requirements indicated.

*1

---
# C_2011030EN.01005703.xml

| 29.1.2011 | EN | Official Journal of the European Union | C 30/57 |
| --- | --- | --- | --- |

29.1.2011

EN

Official Journal of the European Union

C 30/57

---

Order of the General Court (First Chamber) of 1 December 2010 — CEA v Commission

(Case T-412/09) (1)

1

()

2011/C 30/103

Language of the case: French

The President of the First Chamber has ordered that the case be removed from the register.

---

(1)  OJ C 312, 19.12.2009.

1

---
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               DEC-31-1999
<CASH>                                          $4,943
<SECURITIES>                                         0
<RECEIVABLES>                                  $71,210
<ALLOWANCES>                                         0
<INVENTORY>                                    $40,502
<CURRENT-ASSETS>                              $122,229
<PP&E>                                        $748,875
<DEPRECIATION>                                $102,928
<TOTAL-ASSETS>                              $1,515,213
<CURRENT-LIABILITIES>                         $310,125
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       $79,229
<OTHER-SE>                                  $1,463,562
<TOTAL-LIABILITY-AND-EQUITY>                $1,515,213
<SALES>                                     $1,046,342
<TOTAL-REVENUES>                            $1,046,342
<CGS>                                         $345,664
<TOTAL-COSTS>                                 $968,760
<OTHER-EXPENSES>                              $591,431
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             $29,417
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                $(486,347)
<EPS-BASIC>                                     $(.06)
<EPS-DILUTED>                                   $(.06)


</TABLE>
[Federal Register Volume 66, Number 14 (Monday, January 22, 2001)]
[Notices]
[Page 6640]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-1636]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel, Adhesion Molecules in Transfusion Biology.
    Date: January 30, 2001.
    Time: 11 AM to 5 PM.
    Agenda: To review and evaluate grant applications.
    Place: Columbia Sheraton, 10207 Wincopin Circle, Columbia, MD 
21044.
    Contact Person: Jeffrey H. Hurst, Health Scientist 
Administrator, 6701 Rockledge Drive, Room 7208, Bethesda, MD 20892, 
301-435-0303.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: January 12, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-1636 Filed 1-19-01; 8:45 am]
BILLING CODE 4140-01-M
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
          This schedule  contains summary financial  information  extracted from
          Greenland  Corporation and  Subsidiaries  September 30, 1996 financial
          statements  and is  qualified  in its  entirety by  reference  to such
          financial statements
</LEGEND>
<CIK>          0000852127
<NAME>         Greenland Corporation

       
<S>                             <C>

<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                              DEC-31-1996
<PERIOD-END>                                   SEP-30-1996

<CASH>                                         42,511
<SECURITIES>                                   152,893
<RECEIVABLES>                                  125,566
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               214,263
<PP&E>                                         5,376,873
<DEPRECIATION>                                 (280,845)
<TOTAL-ASSETS>                                 9,027,262
<CURRENT-LIABILITIES>                          334,550
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       16,444
<OTHER-SE>                                     4,314,719
<TOTAL-LIABILITY-AND-EQUITY>                   9,027,262
<SALES>                                        0
<TOTAL-REVENUES>                               444,620
<CGS>                                          0
<TOTAL-COSTS>                                  0
<OTHER-EXPENSES>                               713,396
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             251,349
<INCOME-PRETAX>                                (520,125)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (520,125)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (520,125)
<EPS-PRIMARY>                                  (.03)
<EPS-DILUTED>                                  (.03)
        


</TABLE>
# C_2010317EN.01002803.xml

| 20.11.2010 | EN | Official Journal of the European Union | C 317/28 |
| --- | --- | --- | --- |

20.11.2010

EN

Official Journal of the European Union

C 317/28

---

Judgment of the General Court of 7 October 2010 — Deutsche Behindertenhilfe — Aktion Mensch v OHIM (diegesellschafter.de)

(Case T-47/09) (1)

1

(Community trade mark - Application for Community word mark diegesellschafter.de - Absolute ground for refusal - Lack of distinctive character - Article 7(1)(b) of Regulation (EC) No 40/94 (now Article 7(1)(b) of Regulation (EC) No 207/2009))

2010/C 317/51

Language of the case: German

Parties

Parties

Applicant: Deutsche Behindertenhilfe — Aktion Mensch eV (Mayence, Germany) (represented by: V. Töbelmann and A. Piltz, lawyers)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: A. Pohlmann, Agent)

Defendant:

Re:

Re:

Action brought against the decision of the First Board of Appeal of OHIM of 27 November 2008 (Case R 1094/2008-1), concerning an application for registration of the word sign diegesellschafter.de as a Community trade mark.

Operative part of the judgment

Operative part of the judgment

The Court:

| 1. | Dismisses the application; |
| --- | --- |

1.

Dismisses the application;

| 2. | Orders Deutsche Behindertenhilfe — Aktion Mensch eV to pay the costs. |
| --- | --- |

2.

Orders Deutsche Behindertenhilfe — Aktion Mensch eV to pay the costs.

---

(1)  OJ C 102 of 1.5.2009.

1

---
Bruce BIRCH, petitioner, v. Brian E. WILLIAMS, Warden.

No. 17-7874.

Supreme Court of the United States

April 23, 2018.

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.
Andrew Stuart LUSTER, petitioner, v. Joe A. LIZARRAGA, Warden.

No. 17-1117.

Supreme Court of the United States

April 16, 2018.

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.
# C_2009180EN.01005701.xml

| 1.8.2009 | EN | Official Journal of the European Union | C 180/57 |
| --- | --- | --- | --- |

1.8.2009

EN

Official Journal of the European Union

C 180/57

---

Action brought on 28 May 2009 — Yorma's AG v OHIM — Norma Lebensmittelfilialbetrieb (YORMAS’S)

(Case T-213/09)

2009/C 180/105

Language in which the application was lodged: German

Parties

Parties

Applicant: Yorma’s AG (Deggendorf, Germany) (represented by A. Weiß, lawyer)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs)

Defendant:

Other party to the proceedings before the Board of Appeal of OHIM: Norma Lebensmittelfilialbetrieb GmbH & Co. KG

Other party to the proceedings before the Board of Appeal of OHIM:

Form of order sought

Form of order sought

| — | Annul the decision of the First Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) of 20 February 2009 in Case R 1879/2007-1; and |
| --- | --- |

—

Annul the decision of the First Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) of 20 February 2009 in Case R 1879/2007-1; and

| — | Order the defendant to pay the costs. |
| --- | --- |

—

Order the defendant to pay the costs.

Pleas in law and main arguments

Pleas in law and main arguments

Applicant for a Community trade mark: The applicant

Applicant for a Community trade mark:

Community trade mark concerned: Figurative mark composed of a word element ‘YORMA’S’ in blue and yellow for services in Classes 35 and 42 (Registration No 2 048 205)

Community trade mark concerned:

Proprietor of the mark or sign cited in the opposition proceedings: Norma Lebensmittelfilialbetrieb GmbH & Co. KG

Proprietor of the mark or sign cited in the opposition proceedings

Mark or sign cited in opposition: Word mark ‘Norma’ (Community trade mark No 213 769) for goods in Classes 3, 5, 8, 16, 18, 21, 25, 28, 29, 30, 31, 32, 33, 34, 35 and 36 and the commercial symbol ‘NORMA’ used in the course of trade in Germany, as well as the figurative sign ‘NORMA’

Mark or sign cited in opposition:

Decision of the Examiner: Rejection of the opposition.

Decision of the Examiner:

Decision of the Board of Appeal: Annulment of the appealed decision and rejection of the Community trade mark application.

Decision of the Board of Appeal:

Pleas in law: Infringement of Article 8(1)(b) and (4) of Council Regulation No 40/94 (now Article 8(1)(b) and (4) of Regulation (EC) No 207/2009 (1))

Pleas in law:

1

---

(1)  Council Regulation (EC) No 207/2009 of 26 February 2009 on the Community trade mark (OJ 2009 L 78, p. 1).

1

---
Justin BEAVERS, petitioner, v. KERN COUNTY DEPARTMENT OF CHILD SUPPORT SERVICES.

No. 17-725.

Supreme Court of the United States

March 19, 2018.

Petition for rehearing denied.
Exhibit 32.1
**CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER**
**PURSUANT TO 18 U.S.C. SECTION 1350**
     In connection with the accompanying Quarterly Report of Laserscope on Form 10-Q for the threemonths ended March 31, 2005, I, Eric M. Reuter, President and Chief Executive Officer ofLaserscope, hereby certify pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906of the Sarbanes-Oxley Act of 2002, that:
 (1)  such Quarterly Report on Form 10-Q for the three months ended March 31, 2005fully complies with the requirements of section 13(a) or 15(d) of the SecuritiesExchange Act of 1934; and  (2)  the information contained in such Quarterly Report on Form 10-Q for the threemonths ended March 31, 2005 fairly presents, in all material respects, the financialcondition and results of operations of Laserscope.        Date:  May 10, 2005 By:       /s/  Eric M. Reuter         Eric M. Reuter         President and Chief Executive Officer   
A signed original of this written statement required by section 906, or other documentauthenticating, acknowledging, or otherwise adopting the signature that appears in typed formwithin the electronic version of this written statement required by section 906, has been providedto Laserscope and will be retained by Laserscope and furnished to the Securities and ExchangeCommission or its staff upon request.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEET AS OF SEPTEMBER 29, 1997 AND THE CONSOLIDATED
STATEMENT OF INCOME FOR THE NINE MONTHS ENDED SEPTEMBER 29, 1997 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH CONSOLIDATED FINANCIAL STATEMENTS
ON FORM 10-Q.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-29-1997
<PERIOD-START>                             DEC-31-1996
<PERIOD-END>                               SEP-29-1997
<CASH>                                       6,189,000
<SECURITIES>                                         0
<RECEIVABLES>                                7,241,000
<ALLOWANCES>                                 1,076,000
<INVENTORY>                                  5,632,000
<CURRENT-ASSETS>                            20,892,000
<PP&E>                                     219,987,000
<DEPRECIATION>                             124,758,000
<TOTAL-ASSETS>                             158,040,000
<CURRENT-LIABILITIES>                      247,879,000
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         1,000
<OTHER-SE>                                (104,254,000)
<TOTAL-LIABILITY-AND-EQUITY>               158,040,000
<SALES>                                    333,198,000
<TOTAL-REVENUES>                           333,198,000
<CGS>                                      105,406,000
<TOTAL-COSTS>                              185,921,000
<OTHER-EXPENSES>                            14,839,000
<LOSS-PROVISION>                                87,000
<INTEREST-EXPENSE>                          17,688,000
<INCOME-PRETAX>                            (12,759,000)
<INCOME-TAX>                                    48,000
<INCOME-CONTINUING>                        (12,807,000)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (12,807,000)
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>